Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 190

1.

Identification of Endothelin-1 and NR4A2 as CD133-regulated genes in colon cancer cells.

Puglisi MA, Barba M, Corbi M, Errico MF, Giorda E, Saulnier N, Boninsegna A, Piscaglia AC, Carsetti R, Cittadini A, Gasbarrini A, Sgambato A.

J Pathol. 2011 Oct;225(2):305-14. doi: 10.1002/path.2954. Epub 2011 Aug 8.

PMID:
21826669
2.

Description of the CD133+ subpopulation of the human ovarian cancer cell line OVCAR3.

Guo R, Wu Q, Liu F, Wang Y.

Oncol Rep. 2011 Jan;25(1):141-6.

PMID:
21109969
3.

Phenotypic subpopulations of metastatic colon cancer stem cells: genomic analysis.

Botchkina IL, Rowehl RA, Rivadeneira DE, Karpeh MS Jr, Crawford H, Dufour A, Ju J, Wang Y, Leyfman Y, Botchkina GI.

Cancer Genomics Proteomics. 2009 Jan-Feb;6(1):19-29.

4.

Identification of cancer stem cells from human glioblastomas: growth and differentiation capabilities and CD133/prominin-1 expression.

Gambelli F, Sasdelli F, Manini I, Gambarana C, Oliveri G, Miracco C, Sorrentino V.

Cell Biol Int. 2012 Jan;36(1):29-38. doi: 10.1042/CBI20110013.

PMID:
21916848
5.

Biological and genetic characteristics of tumor-initiating cells in colon cancer.

Ieta K, Tanaka F, Haraguchi N, Kita Y, Sakashita H, Mimori K, Matsumoto T, Inoue H, Kuwano H, Mori M.

Ann Surg Oncol. 2008 Feb;15(2):638-48. Epub 2007 Oct 12.

PMID:
17932721
6.

Highly enriched CD133(+)CD44(+) stem-like cells with CD133(+)CD44(high) metastatic subset in HCT116 colon cancer cells.

Chen KL, Pan F, Jiang H, Chen JF, Pei L, Xie FW, Liang HJ.

Clin Exp Metastasis. 2011 Dec;28(8):751-63. doi: 10.1007/s10585-011-9407-7. Epub 2011 Jul 13.

PMID:
21750907
7.

Molecular characterization of CD133+ cancer stem-like cells in endometrial cancer.

Nakamura M, Zhang X, Mizumoto Y, Maida Y, Bono Y, Takakura M, Kyo S.

Int J Oncol. 2014 Mar;44(3):669-77. doi: 10.3892/ijo.2013.2230. Epub 2013 Dec 23.

PMID:
24366104
8.

Protein cross-talk in CD133+ colon cancer cells indicates activation of the Wnt pathway and upregulation of SRp20 that is potentially involved in tumorigenicity.

Corbo C, Orrù S, Gemei M, Noto RD, Mirabelli P, Imperlini E, Ruoppolo M, Vecchio LD, Salvatore F.

Proteomics. 2012 Jun;12(12):2045-59. doi: 10.1002/pmic.201100370.

PMID:
22623141
9.

Post-translational modulation of CD133 expression during sodium butyrate-induced differentiation of HT29 human colon cancer cells: implications for its detection.

Sgambato A, Puglisi MA, Errico F, Rafanelli F, Boninsegna A, Rettino A, Genovese G, Coco C, Gasbarrini A, Cittadini A.

J Cell Physiol. 2010 Jul;224(1):234-41. doi: 10.1002/jcp.22124.

PMID:
20333645
10.

CD49f-positive cell population efficiently enriches colon cancer-initiating cells.

Haraguchi N, Ishii H, Mimori K, Ohta K, Uemura M, Nishimura J, Hata T, Takemasa I, Mizushima T, Yamamoto H, Doki Y, Mori M.

Int J Oncol. 2013 Aug;43(2):425-30. doi: 10.3892/ijo.2013.1955. Epub 2013 May 24.

PMID:
23708747
11.

Side population cell fractions from hepatocellular carcinoma cell lines increased with tumor dedifferentiation, but lack characteristic features of cancer stem cells.

Nakayama M, Ogasawara S, Akiba J, Ueda K, Koura K, Todoroki K, Kinoshita H, Yano H.

J Gastroenterol Hepatol. 2014 May;29(5):1092-101. doi: 10.1111/jgh.12484.

PMID:
24325739
12.

Inhibitory effects of transcription factor Ikaros on the expression of liver cancer stem cell marker CD133 in hepatocellular carcinoma.

Zhang L, Li H, Ge C, Li M, Zhao FY, Hou HL, Zhu MX, Tian H, Zhang LX, Chen TY, Jiang GP, Xie HY, Cui Y, Yao M, Li JJ.

Oncotarget. 2014 Nov 15;5(21):10621-35.

13.

FOXM1-Induced PRX3 Regulates Stemness and Survival of Colon Cancer Cells via Maintenance of Mitochondrial Function.

Song IS, Jeong YJ, Jeong SH, Heo HJ, Kim HK, Bae KB, Park YH, Kim SU, Kim JM, Kim N, Ko KS, Rhee BD, Han J.

Gastroenterology. 2015 Oct;149(4):1006-16.e9. doi: 10.1053/j.gastro.2015.06.007. Epub 2015 Jun 17.

PMID:
26091938
14.

Latexin inhibits the proliferation of CD133+ miapaca-2 pancreatic cancer stem-like cells.

Xue ZX, Zheng JH, Zheng ZQ, Cai JL, Ye XH, Wang C, Sun WJ, Zhou X, Lu MD, Li PH, Cai ZZ.

World J Surg Oncol. 2014 Dec 30;12:404. doi: 10.1186/1477-7819-12-404.

15.

Cytometric profiling of CD133+ cells in human colon 
carcinoma cell lines identifies a common core phenotype 
and cell type-specific mosaics.

Gemei M, Di Noto R, Mirabelli P, Del Vecchio L.

Int J Biol Markers. 2013 Sep 27;28(3):267-73. doi: 10.5301/JBM.5000020.

PMID:
23709346
16.

CD133 and CD44 are universally overexpressed in GIST and do not represent cancer stem cell markers.

Chen J, Guo T, Zhang L, Qin LX, Singer S, Maki RG, Taguchi T, Dematteo R, Besmer P, Antonescu CR.

Genes Chromosomes Cancer. 2012 Feb;51(2):186-95. doi: 10.1002/gcc.20942. Epub 2011 Nov 10.

17.

[Application of genome-wide genechip for screening and identifying genes related to CD133(+)CD200(+) colorectal cancer stem cells].

Zhang S, Li L, Huang Z, Xin X, Xiao B.

Nan Fang Yi Ke Da Xue Xue Bao. 2013 Dec;33(12):1787-91. Chinese.

18.

miRNA expression profile of colon cancer stem cells compared to non-stem cells using the SW1116 cell line.

Fang Y, Xiang J, Chen Z, Gu X, Li Z, Tang F, Zhou Z.

Oncol Rep. 2012 Dec;28(6):2115-24. doi: 10.3892/or.2012.2054. Epub 2012 Sep 24.

PMID:
23007737
19.

A gene signature distinguishing CD133hi from CD133- colorectal cancer cells: essential role for EGR1 and downstream factors.

Ernst A, Aigner M, Nakata S, Engel F, Schlotter M, Kloor M, Brand K, Schmitt S, Steinert G, Rahbari N, Koch M, Radlwimmer B, Weitz J, Lichter P.

Pathology. 2011 Apr;43(3):220-7. doi: 10.1097/PAT.0b013e328344e391.

PMID:
21436631
20.

The importance of the stem cell marker prominin-1/CD133 in the uptake of transferrin and in iron metabolism in human colon cancer Caco-2 cells.

Bourseau-Guilmain E, Griveau A, Benoit JP, Garcion E.

PLoS One. 2011;6(9):e25515. doi: 10.1371/journal.pone.0025515. Epub 2011 Sep 26.

Supplemental Content

Support Center